Pages that link to Additive QTc Prolongation with Concurrent Use of Bedaquiline, Clofazimine, and Fluoroquinolones in MDR-TB: Role of Hypokalemia and Hypomagnesemia as Modifying Risk Factors
Primary tabs
Cite This Article
Vancouver Style ::
Additive QTc Prolongation with Concurrent Use of Bedaquiline, Clofazimine, and Fluoroquinolones in MDR-TB: Role of Hypokalemia and Hypomagnesemia as Modifying Risk Factors. Pharmacognosy Journal. 2026;18(3):348-357.
PDF (248.98 KB)
PDF (248.98 KB)
No backlinks found.